Can drinking ketone supplements, a.k.a exogenous ketones, help manage your blood sugar or improve your health? Might exogenous ketones even improve heart function, treat heart failure, or possibly reduce the symptoms of Alzheimer’s disease?
These are some of the intriguing research questions that will be explored by Dr. Jonathan Little, PhD, during his 90-minute IPTN webinar on Wednesday, January 17, 2024 at 5 pm Pacific.
Dr. Little is a Professor, in the School of Health and Exercise Sciences and Centre for Chronic Disease Prevention and Management at the University of British Columbia Okanagan, whose laboratory has been studying exogenous ketones.
“There has been a surge in interest around ketosis and health,” explains Professor Little, who is also the Chief Scientific Officer of the IPTN. “The research around exogenous ketones is helping us understand that ketones can serve as an alternate fuel for the body and also have hormone-like signaling properties that impact the immune system, cardiovascular function, and metabolic control.”
In his presentation, Professor Little will provide an overview of the historic development and theoretical understanding of exogenous ketone supplements; he will also summarize the research literature, especially around ketones' application to sports performance, glucose control and metabolism, cardiac health, and cognition.
“The development of exogenous ketone supplements has enabled scientists to study a unique metabolic environment. Within minutes of drinking ketones or their precursors, we see large increases in circulating ketones, allowing us to more directly assess what ketones do to physiology,” notes Professor Little.
Professor Little will not only summarize the global research literature, he will present a series of studies in his laboratory, starting in healthy young participants and progressing to individuals with obesity and type 2 diabetes, demonstrating acute glucose-lowering effects of exogenous ketone supplementation. He’ll describe how the unique anti-inflammatory and glucose-regulating properties of exogenous ketones might be harnessed as a potential therapy for type 2 diabetes, although this research is still in the proof-of-concept phase.
His webinar will also explore some of the other emerging clinical conditions where exogenous ketones are producing encouraging therapeutic findings, including age-related cognitive decline and heart failure.
Whether you are a researcher or a practitioner with interests in nutrition therapy, metabolism, diabetes, cardiovascular disease, cognitive/brain health, and immunology/inflammation, this webinar is one not to miss. It will give you a state-of-the-art overview of the hot topic of exogenous ketone supplements.